Bipolar disorder is a lifelong mood disorder that affects approximately 2.8% of U.S. adults annually, with lifetime prevalence approaching 4.4%4. While often diagnosed in late adolescence or early adulthood, early symptoms—such as mood lability, irritability, or depressive episodes—can present in younger patients, making early identification in primary care and pediatric settings essential1. Genetic predisposition plays a significant role, with up to 90% of individuals having a first-degree relative with a mood disorder2. Co-occurring conditions, such as substance use disorders, cardiovascular disease, and metabolic syndrome, are common and should be regularly screened for in both medical and behavioral health settings.

Bipolar disorder is also associated with elevated suicide risk and reduced life expectancy, by an average of 9 to 17 years, largely due to medical comorbidities and suicide4,5. An estimated 10–20% of individuals with bipolar disorder die by suicide, and up to 60% may attempt it at least once, often with high lethality3. Integrated care coordination between primary care and behavioral health providers is crucial to ensure continuity of care, monitor treatment adherence, and manage risks. Evidence-based approaches include mood stabilizers, psychotherapy, and routine follow-up, especially during transitions of care. 

  1. American Academy of Pediatrics. (2018). Mental health disorders in adolescents. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management 

  2. American Psychiatric Association. (2023). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). Washington, DC: Author.

  3. Goodwin, F. K., & Jamison, K. R. (2007). Manic-depressive illness: Bipolar disorders and recurrent depression (2nd ed.). Oxford University Press.

  4. National Institute of Mental Health. (2022). Bipolar disorder

  5. World Health Organization. (2017). Depression and other common mental disorders: Global health estimates. 

Indication(s) Pharmacologic Class Common Brand Names & Formulations Generic Name
Acute mania or mixed episode, maintenance  Antimanic Agents
  • Lithobid
Lithium carbonate
Acute mania or mixed episode, maintenance  Anticonvulsants
  • Depakote
  • Depakote ER (extended release)
Valproic acid
Maintenance  Anticonvulsants
  •  Lamictal 
Lamotrigine
Acute mania or mixed episode Anticonvulsants
  •  Tegretol 
Carbamazepine
Acute mania or mixed episode, maintenance  Atypical Antipsychotics
  •  Abilify 
Aripiprazole
Acute mania or mixed episode Atypical Antipsychotics
  •  Saphris 
Asenapine
Acute mania or mixed episode, maintenance  Atypical Antipsychotics
  •  Vraylar 
Cariprazine
Bipolar depression Atypical Antipsychotics
  •  Latuda 
Lurasidone
Acute mania or mixed episode, maintenance Atypical Antipsychotics
  •  Zyprexa 
Olanzapine
Acute bipolar depression Atypical Antipsychotics
  •  Symbyax 
Olanzapine-fluoxetine
Acute mania, acute bipolar depression Atypical Antipsychotics
  •  Seroquel 
Quetiapine
Acute mania or mixed episode Atypical Antipsychotics
  •  Risperdal 
Risperidone
Acute mania or mixed episode Atypical Antipsychotics
  •  Geodon 
Ziprasidone